Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionArjuna Capital
Latest Disclosed Ownership7,889 shares
Latest Disclosed Value $ 2,775,745
Arjuna Capital reports 5.50% increase in ownership of AMGN / Amgen Inc.

On May 6, 2026 - Arjuna Capital filed a 13F-HR form disclosing ownership of 7,889 shares of Amgen Inc. (MX:AMGN) valued at $2,775,745 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 7,478 shares of Amgen Inc.. This represents a change in shares of 5.50% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F AMGEN COM 031162100 7,889 411 5.50 2,776 13.40 0.7058
2026-02-05 2025-12-31 13F AMGEN COM 031162100 7,478 55 0.74 2,448 16.86 0.5997
2025-11-04 2025-09-30 13F AMGEN COM 031162100 7,423 153 2.10 2,095 3.20 0.5207
2025-08-13 2025-06-30 13F AMGEN COM 031162100 7,270 -262 -3.48 2,030 -13.51 0.5351
2025-05-09 2025-03-31 13F AMGEN COM 031162100 7,532 -13,712 -64.55 2,347 -57.63 0.6495
2025-02-07 2024-12-31 13F AMGEN COM 031162100 21,244 -1,069 -4.79 5,537 -22.98 1.4734
2024-11-05 2024-09-30 13F AMGEN COM 031162100 22,313 -2,816 -11.21 7,189 -8.43 1.8620
2024-07-29 2024-06-30 13F AMGEN COM 031162100 25,129 987 4.09 7,852 14.38 2.1125
2024-05-13 2024-03-31 13F AMGEN COM 031162100 24,142 8,893 58.32 6,864 56.28 1.9461
2024-02-08 2023-12-31 13F AMGEN COM 031162100 15,249 1,871 13.99 4,392 22.17 1.3747
2023-11-09 2023-09-30 13F AMGEN COM 031162100 13,378 -9,475 -41.46 3,595 -29.13 1.2879
2023-08-09 2023-06-30 13F AMGEN COM 031162100 22,853 614 2.76 5,074 -5.64 1.7976
2023-05-15 2023-03-31 13F AMGEN COM 031162100 22,239 818 3.82 5,376 -4.44 2.1091
2023-02-06 2022-12-31 13F AMGEN COM 031162100 21,421 721 3.48 5,626 20.57 2.5941
2022-11-01 2022-09-30 13F AMGEN COM 031162100 20,700 1,266 6.51 4,666 -1.31 2.2940
2022-07-22 2022-06-30 13F AMGEN COM 031162100 19,434 339 1.78 4,728 2.38 2.2892
2022-05-12 2022-03-31 13F AMGEN COM 031162100 19,095 -1,416 -6.90 4,618 0.09 1.9248
2022-02-11 2021-12-31 13F AMGEN COM 031162100 20,511 -64 -0.31 4,614 5.46 1.6894
2021-11-08 2021-09-30 13F AMGEN COM 031162100 20,575 1,116 5.74 4,375 -7.76 1.7779
2021-08-11 2021-06-30 13F AMGEN COM 031162100 19,459 1,015 5.50 4,743 3.36 2.0501
2021-05-11 2021-03-31 13F AMGEN COM 031162100 18,444 1,151 6.66 4,589 15.42 2.2565
2021-02-09 2020-12-31 13F AMGEN COM 031162100 17,293 416 2.46 3,976 -7.30 2.2008
2020-11-05 2020-09-30 13F AMGEN COM 031162100 16,877 230 1.38 4,289 9.25 2.6617
2020-08-13 2020-06-30 13F AMGEN COM 031162100 16,647 -1,408 -7.80 3,926 7.27 2.7085
2020-05-11 2020-03-31 13F AMGEN COM 031162100 18,055 -296 -1.61 3,660 -17.27 3.0535
2020-01-30 2019-12-31 13F AMGEN COM 031162100 18,351 -544 -2.88 4,424 21.01 3.2027
2019-11-06 2019-09-30 13F AMGEN COM 031162100 18,895 247 1.32 3,656 6.40 3.1175
2019-08-21 2019-06-30 13F/A-1 AMGEN COM 031162100 18,648 978 5.53 3,436 2.35 2.4703
2019-08-08 2019-06-30 13F AMGEN COM 031162100 18,439 769 3,398
2019-05-14 2019-03-31 13F AMGEN COM 031162100 17,670 -179 -1.00 3,357 -3.40 2.5956
2019-01-31 2018-12-31 13F AMGEN COM 031162100 17,849 -266 -1.47 3,475 -7.46 3.1649
2018-11-14 2018-09-30 13F AMGEN COM 031162100 18,115 125 0.69 3,755 13.07 2.8250
2018-08-01 2018-06-30 13F AMGEN COM 031162100 17,990 142 0.80 3,321 9.14 2.7061
2018-04-24 2018-03-31 13F AMGEN COM 031162100 17,848 3,236 22.15 3,043 19.76 2.5668
2018-02-09 2017-12-31 13F AMGEN COM 031162100 14,612 14,612 2,541 2.3793
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.